Brief: PCI Biotech CEO Resigns

PCI Biotech Holding ASA

28/03/2022 13:29

March 28 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * REG-PCI BIOTECH: CEO RESIGNS TO ASSUME NEW POSITION
    * ANNOUNCES TODAY THAT CEO, DR PER WALDAY HAS RESIGNED TO
ASSUME A
NEW POSITION
    * DR WALDAY HAS A NOTICE PERIOD OF SIX MONTHS, AND HE WILL
STEP
DOWN FROM HIS POSITION BY END OF SEPTEMBER 2022, OR EARLIER
    * BOARD OF DIRECTORS WILL INITIATE A SUCCESSION PROCESS.

Source text for Eikon:  ID:nGNE4zfjWR 
Further company coverage:  PCIB.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))